99% Savings - Buy Just @1 Rs X
Biproate 333 Mg/145 Mg Tablet CR is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Epilepsy. The alternative uses of Biproate 333 Mg/145 Mg Tablet CR have also been explained below.
The right dosage of Biproate 333 Mg/145 Mg Tablet CR depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Common side effects of Biproate 333 Mg/145 Mg Tablet CR include Loss of appetite. Besides the aforementioned side effects, there are other adverse effects of Biproate 333 Mg/145 Mg Tablet CR as well, which are listed below. Usually, these side effects of Biproate 333 Mg/145 Mg Tablet CR go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Biproate 333 Mg/145 Mg Tablet CR's effect during pregnancy is Severe and Mild while nursing. In addition, Biproate 333 Mg/145 Mg Tablet CR's effects on the liver, heart and kidney are discussed below in the Biproate 333 Mg/145 Mg Tablet CR related warnings section.
Biproate 333 Mg/145 Mg Tablet CR is contraindicated in people with pre-existing medical conditions like Depression as it can result in adverse effects. The section on Biproate 333 Mg/145 Mg Tablet CR contraindications lists all such conditions.
Besides this, Biproate 333 Mg/145 Mg Tablet CR may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Biproate 333 Mg/145 Mg Tablet CR, it is important to know that it is not safe while driving, and is not habit-forming.
Biproate 333 Mg/145 Mg Tablet CR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Biproate 333 Mg/145 Mg Tablet CR safe for pregnant women?
Pregnant women may get severe side effects after taking Biproate Cr. If you are pregnant, do not take Biproate Cr without a doctor's advice.
Is the use of Biproate 333 Mg/145 Mg Tablet CR safe during breastfeeding?
Breastfeeding women can take Biproate Cr as it bears very minor side effects for them.
What is the effect of Biproate 333 Mg/145 Mg Tablet CR on the Kidneys?
Biproate Cr rarely harms the kidneys.
What is the effect of Biproate 333 Mg/145 Mg Tablet CR on the Liver?
Biproate Cr has very mild side effects on the liver.
What is the effect of Biproate 333 Mg/145 Mg Tablet CR on the Heart?
There are no any side effects of Biproate Cr for the heart.
If you are suffering from any of the following diseases, you should not take Biproate 333 Mg/145 Mg Tablet CR unless your doctor advises you to do so -
Is this Biproate 333 Mg/145 Mg Tablet CR habit forming or addictive?
No, there is no any evidence that Biproate 333 Mg/145 Mg Tablet CR is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Biproate 333 Mg/145 Mg Tablet CR as you may feel sleepy.
Is it safe?
Yes, but consume Biproate 333 Mg/145 Mg Tablet CR only on doctor's advice.
Is it able to treat mental disorders?
Yes, Biproate 333 Mg/145 Mg Tablet CR is useful in treating mental disorders.
Interaction between Food and Biproate 333 Mg/145 Mg Tablet CR
It is safe to take Biproate 333 Mg/145 Mg Tablet CR with food.
Interaction between Alcohol and Biproate 333 Mg/145 Mg Tablet CR
Taking alcohol with Biproate 333 Mg/145 Mg Tablet CR can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1243-1245
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stavzor (valproic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)